Procter & Gamble Hygiene and Health Care Limited (PGHH) - Total Liabilities
Based on the latest financial reports, Procter & Gamble Hygiene and Health Care Limited (PGHH) has total liabilities worth Rs10.50 Billion INR (≈ $113.56 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Procter & Gamble Hygiene and Health Care to track the company's year-over-year net asset growth rate.
Procter & Gamble Hygiene and Health Care Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Procter & Gamble Hygiene and Health Care Limited's total liabilities have evolved over time, based on quarterly financial data. See PGHH FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Procter & Gamble Hygiene and Health Care Limited Competitors by Total Liabilities
The table below lists competitors of Procter & Gamble Hygiene and Health Care Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang JIULI Hi-tech Metals Co Ltd
SHE:002318
|
China | CN¥4.35 Billion |
|
Sinch AB
ST:SINCH
|
Sweden | Skr18.44 Billion |
|
The Marzetti Company
NASDAQ:MZTI
|
USA | $311.26 Million |
|
Charoen Pokphand Indonesia TBK PT
JK:CPIN
|
Indonesia | Rp11.81 Trillion |
|
Xiamen Bank Co Ltd
SHG:601187
|
China | CN¥415.45 Billion |
|
Organización Soriana S. A. B. de C. V
MX:SORIANAB
|
Mexico | MX$76.03 Billion |
|
Cinemark Holdings Inc
NYSE:CNK
|
USA | $4.04 Billion |
|
Guizhou Chanhen Chemical Corp
SHE:002895
|
China | CN¥4.65 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Procter & Gamble Hygiene and Health Care Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Procter & Gamble Hygiene and Health Care stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Procter & Gamble Hygiene and Health Care Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Procter & Gamble Hygiene and Health Care Limited (2004–2025)
The table below shows the annual total liabilities of Procter & Gamble Hygiene and Health Care Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | Rs10.18 Billion ≈ $110.06 Million |
-6.09% |
| 2024-06-30 | Rs10.84 Billion ≈ $117.20 Million |
-9.03% |
| 2023-06-30 | Rs11.91 Billion ≈ $128.83 Million |
+26.24% |
| 2022-06-30 | Rs9.44 Billion ≈ $102.05 Million |
+2.75% |
| 2021-06-30 | Rs9.18 Billion ≈ $99.33 Million |
+36.97% |
| 2020-06-30 | Rs6.71 Billion ≈ $72.52 Million |
-7.24% |
| 2019-06-30 | Rs7.23 Billion ≈ $78.17 Million |
+16.62% |
| 2018-06-30 | Rs6.20 Billion ≈ $67.03 Million |
-2.23% |
| 2017-06-30 | Rs6.34 Billion ≈ $68.56 Million |
-2.97% |
| 2016-06-30 | Rs6.53 Billion ≈ $70.66 Million |
-9.13% |
| 2015-06-30 | Rs7.19 Billion ≈ $77.76 Million |
+42.36% |
| 2014-06-30 | Rs5.05 Billion ≈ $54.62 Million |
+28.61% |
| 2013-06-30 | Rs3.93 Billion ≈ $42.47 Million |
-2.19% |
| 2012-06-30 | Rs4.01 Billion ≈ $43.42 Million |
+40.89% |
| 2011-06-30 | Rs2.85 Billion ≈ $30.82 Million |
-2.47% |
| 2010-06-30 | Rs2.92 Billion ≈ $31.60 Million |
+38.11% |
| 2009-06-30 | Rs2.12 Billion ≈ $22.88 Million |
-2.59% |
| 2008-06-30 | Rs2.17 Billion ≈ $23.49 Million |
+32.50% |
| 2007-06-30 | Rs1.64 Billion ≈ $17.73 Million |
-3.53% |
| 2006-06-30 | Rs1.70 Billion ≈ $18.38 Million |
-35.98% |
| 2005-06-30 | Rs2.65 Billion ≈ $28.70 Million |
+14.31% |
| 2004-06-30 | Rs2.32 Billion ≈ $25.11 Million |
-- |
About Procter & Gamble Hygiene and Health Care Limited
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as femin… Read more